Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The failure led Metabolic Pharmaceuticals to effectively terminate development of AOD 9604 as a weight loss drug
In January 2024, the FDA clarified its position: peptides like research peptides and many others frequently marketed by peptide clinics are not approved for any use and cannot be legally compounded
Obese Zucker rats treated with AOD-9604 at 500 mcg/kg/day for 19 days showed a statistically significant reduction in body fat compared to vehicle-treated controls
The combination with NMN and metabolic research blends enables investigation of cellular energy regulation and NAD pathway dynamics
Who May Explore GHK-Cu Under Supervision
US$ 24.65
US$ 27.18
US$ 26.35
US$ 21.46
